Archives
Exo1 Workflows for Exocytosis and TEV Research
2026-08-11
Exo1 enables acute membrane trafficking inhibition through a mechanism that distinguishes ARF1 release from Golgi membranes from BFA-associated effects. This guide translates that profile into practical exocytosis assays, extracellular vesicle workflows, controls, and troubleshooting strategies for preclinical cell research.
AO/PI Double Staining Kit for Cell-Death Trajectories
2026-08-11
The AO/PI Double Staining Kit transforms rapid cell viability assay results into a time-resolved view of apoptosis and necrosis. This guide explains how to interpret fluorescence phenotypes alongside orthogonal evidence from a melanoma treatment study.
740 Y-P: PI 3-Kinase Activator Guide
2026-08-10
740 Y-P is a cell-permeable PI 3-kinase activator for controlled modulation of PI3K/AKT signaling in cell and biochemical research. Evidence spans vesicular trafficking, neuronal cell survival, melanoma-cell models, and pathway validation in mitophagy research.
Deferasirox Fe3+ Chelate in Lysosome Research
2026-08-09
Use Deferasirox Fe3+ chelate as a controlled chemical probe when studying ferric-iron handling, glucose starvation, ferritinophagy, and lysosome-dependent cell death. This workflow combines solvent-aware formulation with the TCF25–V-ATPase findings from a recent CRISPR study to improve mechanistic resolution without confusing a preformed Fe3+ complex with free deferasirox.
DiI (DiIC18(3)) Plasma Membrane Probe
2026-08-08
DiI (DiIC18(3)) provides orange-red labeling of lipid membranes for live or fixed-cell imaging, neuronal tracing, migration studies, and membrane-associated assays. It is lipophilic and water-insoluble, so it should not be selected for aqueous-only workflows or experiments requiring exclusive intracellular organelle staining.
ABT-263 (Navitoclax) for Apoptosis Assays
2026-08-07
ABT-263 (Navitoclax) converts Bcl-2-family dependence into a measurable mitochondrial apoptosis phenotype, supporting dose-response, priming, and combination studies. This workflow pairs the compound with orthogonal caspase and transcriptional-state measurements inspired by a 2025 Cell study while separating assay recommendations from product specifications.
CB-5083 and p97 Inhibition: Unveiling New Frontiers in Prote
2026-08-07
Explore how CB-5083, a potent p97 inhibitor, advances the study of protein homeostasis disruption and cancer cell apoptosis induction. This article uniquely connects recent insights on stress granule dynamics and ER stress to CB-5083's practical application in oncology and neurodegeneration research.
O-GlcNAcylation Enables Wnt-Induced Bone Formation via Glyco
2026-08-06
This study reveals that O-GlcNAcylation is essential for Wnt-driven bone formation, mechanistically linking Wnt signaling to glycolytic reprogramming in osteoblasts. By uncovering how Wnt3a-mediated O-GlcNAcylation of PDK1 stabilizes glycolytic flux, the work provides a critical metabolic perspective on osteogenesis with implications for bone disease therapies.
Thymoquinone Mitigates Doxorubicin Cardiotoxicity via Nrf2/H
2026-08-06
This study provides the first direct evidence that thymoquinone, a bioactive quinone from Nigella sativa, protects against doxorubicin-induced cardiac injury in mice by activating the Nrf2/HO-1 pathway and reducing ferroptosis. The findings clarify the molecular mechanisms underlying thymoquinone's cardioprotective effects and offer concrete parameters for preclinical cardiac toxicity models.
FXR-KLF11 Axis: CDCA Suppresses JAK2/STAT3 in AKI Models
2026-08-05
This study identifies the FXR-KLF11 axis as a key protective mechanism against contrast-induced acute kidney injury (CI-AKI). By activating FXR with CDCA, researchers demonstrated transcriptional upregulation of KLF11 and subsequent suppression of the JAK2/STAT3 pathway, providing mechanistic insight for future interventions in kidney injury and nuclear receptor signaling research.
Amyloid β-Peptide (1-42): Ferroptosis, Ion Channels, and AD
2026-08-05
Explore the scientific basis of Amyloid β-Peptide (1-42) in Alzheimer's disease research, with a focus on ferroptosis, neuronal ion channel modulation, and assay design. This article uniquely connects mechanistic insights with cutting-edge findings for advanced laboratory applications.
Thioguanine in Applied Research: Protocols and Troubleshooti
2026-08-04
Thioguanine (6-thioguanine) is a high-impact reagent for cancer, antiviral, and immunomodulatory studies—uniquely bridging DNA methyltransferase 1 inhibition and autophagy modulation. This article translates bench-proven workflows, troubleshooting tips, and latest comparative research into actionable protocols for advanced experimental design.
Hepatic sEH–Nrf2 Axis Regulates Osteoclastogenesis in Osteop
2026-08-04
This study uncovers a novel liver-bone signaling axis in osteoporosis, showing that hepatic soluble epoxide hydrolase (sEH) promotes osteoclast differentiation by suppressing Nrf2 signaling, thereby contributing to redox imbalance and bone loss. These findings highlight the translational potential of sEH inhibitors for dissecting bone metabolism and inflammatory pathways in advanced disease models.
Applied Workflows with Substance P: Optimizing Pain Transmis
2026-08-03
Substance P from APExBIO offers bench scientists a high-purity, reproducible tachykinin neuropeptide to dissect pain, inflammation, and immune pathways. This article translates emerging spectral interference solutions and hands-on assay troubleshooting into practical guidance, enabling robust, interference-free neurokinin signaling studies.
Pepstatin A: Elevating Aspartic Protease Inhibition in Trans
2026-08-03
This thought-leadership article explores the mechanistic precision and translational impact of Pepstatin A as an aspartic protease inhibitor. Integrating recent mechanistic insights and protocol recommendations, it guides researchers through optimized experimental design for viral protein processing and osteoclast differentiation inhibition, while contextualizing APExBIO’s ultra-pure Pepstatin A as a new benchmark. The discussion bridges foundational enzymology with actionable translational strategies and offers a forward-looking perspective grounded in cutting-edge literature.
799 records 10/54 page Previous Next First page 上5页 678910 下5页 Last page